## TXN: Texas Instruments Incorporated - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%); PEG 1.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($166.71)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 2)

**1. Texas Instruments' $40 billion semiconductor factory brings thousands of jobs to North Texas**
- Source: CBS News | 20251217T223250 | Bullish | Relevance: 100%
- Texas Instruments' new $40 billion semiconductor factory in Sherman, North Texas, has officially started production. This facility will produce critical chips for various electronics and is expected to create 3,000 direct jobs for Dallas-based TI, plus thousands more supportive roles. Governor Greg Abbott and the Biden administration have supported the project, highlighting its importance for the economy and domestic supply chain.

**2. Texas Instruments starts production at new Sherman fab**
- Source: The Business Journals | 20251217T190829 | Bullish | Relevance: 100%
- Texas Instruments has begun production at its new semiconductor fabrication plant in Sherman, Texas. The chip factory, celebrated with a ribbon-cutting ceremony attended by dignitaries including Gov. Greg Abbott and TI CEO Haviv Ilan, marks TI's latest investment in the semiconductor industry. This facility allows a glimpse into the company's efforts in the ongoing semiconductor arms race.

**3. Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)**
- Source: ts2.tech | 20251216T180924 | Neutral | Relevance: 100%
- Texas Instruments (TXN) is navigating contrasting forces as Goldman Sachs downgrades its stock to Sell with a cut price target due to concerns over inventory, depreciation, and slower analog chip recovery. Meanwhile, the company celebrates a significant milestone with its Sherman, Texas, semiconductor factory expected to begin production this week, reinforcing its long-term manufacturing strategy. Investors are weighing the immediate financial optics of capacity investments against the strategic advantage of its U.S. manufacturing buildout.

**4. Texas Instruments Inc (NASDAQ:TXN) Gets Double Downgraded**
- Source: FXDailyReport.Com | 20251216T170851 | Bearish | Relevance: 100%
- Goldman Sachs has double downgraded Texas Instruments Inc (NASDAQ:TXN) to Sell from Buy, citing "lackluster" execution and less leverage than peers in the semiconductor upcycle. The firm set a new price target of $156, down from $200. Goldman Sachs analysts believe the company's strategic capacity and capital choices will hinder its margin and earnings recovery relative to competitors.

**5. Texas Instruments Incorporated $TXN Shares Sold by Thurston Springer Miller Herd & Titak Inc.**
- Source: MarketBeat | 20251217T141409 | Somewhat-Bearish | Relevance: 100%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its stake in Texas Instruments (NASDAQ:TXN) by 93.1% in the third quarter, selling 23,748 shares and retaining 1,772 shares valued at $326,000. Despite this sell-off, other institutional investors like Norges Bank and Soundwatch Capital LLC increased their holdings substantially. Company insiders also sold shares, with VP Christine Witzsche selling 1,000 shares and Director Ronald Kirk selling 9,990 shares.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Goldman Sachs | $156 | $200 | -22% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Goldman Sachs | down | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.53M) |
| Sells | 4 ($0.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.6% (+1.1%)
- Blackrock Inc.: 8.5% (+0.1%)
- JPMORGAN CHASE & CO: 6.0% (+80.5%)
- State Street Corpora: 4.8% (+0.5%)
- Charles Schwab Inves: 2.5% (+3.9%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.57 elevated, pricing in significant growth expectations. Forward P/E 28.8x stretched relative to 12% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 29%). Balance sheet: strong liquidity (4.5x). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $160.2B |
| Beta | 0.99 |
| 52W Range | $139.95 - $221.69 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.57 |
| Forward P/E | 28.8 |
| Current P/E | 32.2 |
| YoY Growth | 11.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.4% to -0.4% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 55. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.42% (CS: 32) | Neutral |
| RSI_14 | 54.9 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 0.970x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $176.19
- **Stop Loss:** $166.71 (5.4% risk)
- **Target:** $185.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 100
- **Position Value:** $17,619.00
- **Portfolio %:** 17.62%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-20 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.49 | $1.48 | -0.4% |
| 2025Q2 | $1.33 | $1.41 | +5.8% |
| 2025Q1 | $1.06 | $1.28 | +20.2% |
| 2024Q4 | $1.20 | $1.30 | +8.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*